Bitcoin price today: tumbles below $90k as Fed cut doubts spark risk-off mood
BeOne Medicines Ltd. (EXCHANGE:ONC) President and COO Wu Xiaobin sold 14,153 American Depositary Shares of the company on November 12 and 13, 2025, for a total of $5.85 million. The sales occurred at prices ranging from $350.441 to $381.0497.
Following these transactions, Wu directly owns 1,020,861 ordinary shares, 1,769 American Depositary Shares, and indirectly owns 4,000 American Depositary Shares through his wife. The 1,020,861 ordinary shares includes 650 ordinary shares acquired pursuant to the Company’s Fourth Amended and Restated 2018 Employee Share Purchase Plan. Each American Depositary Share represents 13 Ordinary Shares.
In other recent news, BeOne Medicines reported impressive financial results for the third quarter of 2025. The company achieved a non-GAAP diluted earnings per share (EPS) of $2.65, which significantly exceeded the forecasted $0.80. Additionally, BeOne Medicines surpassed revenue expectations, bringing in $1.41 billion compared to the anticipated $1.37 billion. These results highlight the company’s strong performance in the recent quarter. The earnings and revenue figures are crucial data points for investors assessing the company’s financial health. No recent mergers or acquisitions were reported for BeOne Medicines. Analyst upgrades or downgrades were not mentioned in the latest updates. These recent developments provide investors with a snapshot of BeOne Medicines’ current financial standing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
